For Institutions
About
Global pharmaceutical giants Eli Lilly and Novo Nordisk are competing in India's growing obesity drug market, which is expected to exceed US$1 billion within two years. Lilly's Mounjaro and Novo's Wegovy are leading the market, with Novo cutting prices to compete. Over 20 Indian drug makers plan to launch cheaper generics by 2026. The market is expanding beyond urban elites to middle-class families and smaller towns. Lilly has partnered with Cipla and Apollo Hospitals to increase reach.
NVIDIA shares climbed to $190.16 in overnight trading following the company's $20 billion licensing agreement with AI chip startup Groq.
Quantum computing stocks like IonQ, Rigetti Computing, and D-Wave Quantum outperformed the S&P 500 in 2025. Nvidia is building a quantum computing suite, offering software (CUDA-Q) and hardware (NVQLink) to bridge quantum and classical computing. Nvidia's growth is tied to AI infrastructure, expected to be a $7 trillion opportunity by 2030. Nvidia's stock is reasonably valued and poised for further growth, making it a compelling long-term investment.
Investor Ross Gerber shared mixed reviews of Tesla's FSD v14 system, noting its ineffectiveness in rain as the camera mistakes raindrops for debris. Despite previous praise for improvements, Gerber's trial run highlighted limitations in adverse weather. Meanwhile, Elon Musk claimed successful autonomous rides in Austin, aligning with Tesla's driverless goals. TSLA's stock slightly declined by 0.11% to $485.03 in after-hours trading.
Google is rolling out a new feature in India allowing users to change their @gmail.com addresses while keeping all account data intact. The original address becomes an alternate email, and users can log in with either address. The feature is currently limited to India and may not be available to everyone yet. Analysts remain bullish on Alphabet, with strong growth and advertising revenue resilience. GOOG stock has gained 60.16% over the past 12 months and is trading near its highs.
